T2	Exp 70 84	the activation
T3	Exp 88 123	the NF-kappa B transcription factor
T4	Exp 249 251	we
T5	Exp 257 261	that
T6	Exp 307 321	the expression
T7	Exp 237 247	this study
T8	Exp 508 537	its inactive cytoplasmic form
T9	Exp 433 438	which
T10	Exp 371 381	The effect
T11	Exp 397 432	the NF-kappa B transcription factor
T12	Exp 599 604	which
T13	Exp 617 628	the effects
T14	Exp 695 709	the activation
T15	Exp 776 790	the activation
T16	Exp 956 960	that
T17	Exp 1093 1106	the synthesis
T18	Exp 1182 1193	the release
T19	Exp 1197 1229	the inhibitory subunit I kappa B
R4	Coref Anaphora:T9 Antecedent:T11
R5	Coref Anaphora:T8 Antecedent:T20
R6	Coref Anaphora:T12 Antecedent:T21
T1	Protein 863 872	TNF-alpha
T20	Exp 476 493	an H2O2 treatment
T21	Exp 566 598	a well characterized antioxidant
